Literature DB >> 12169863

Risk factors for hip fracture in hemodialysis patients.

Hiroshi Kaji1, Mizune Suzuki, Shozo Yano, Toshitsugu Sugimoto, Kazuo Chihara, Saburo Hattori, Kenichi Sekita.   

Abstract

BACKGROUND: The incidence and mortality of hip fractures were several times greater in the patients with hemodialysis (HD) than in the general population. Although patients with end-stage renal disease develop renal osteodystrophy, few published data examined the risk factor of hip fractures in the dialysis population.
METHODS: The present study was performed to compare various indices and bone mineral density (BMD) of HD patients with or without the history of hip fractures. Moreover, we analyzed the factors which predicted hip fractures in 183 patients with chronic HD enrolled in the cross-sectional study.
RESULTS: Serum level of alkaline phosphatase was significantly higher in HD patients with hip fractures, compared to those without hip fractures. Oral calcium carbonate dose was significantly lower in HD patients with hip fractures. 1/3 radius (R)-BMD and ultradistal (UD)R-BMD were significantly lower in HD patients with hip fractures. However, lumbar spine (LS)-BMD was comparable in HD patients with or without hip fractures. Although there was no significant differences of BMD between with and without hip fractures in diabetes mellitus, UDR-BMD of patients with hip fractures was significantly lower than that of patients without hip fractures in chronic glomerulonephritis. Radial BMD was lower in female patients with hip fractures, compared to without hip fractures, although there were no significant differences in male patients. In multiple logistic regression analysis, oral calcitriol dose and 1/3R-BMD were selected as a risk factor of hip fractures in HD patients.
CONCLUSION: Radial BMD was lower in HD patients with hip fractures. However, its contribution is different, depending on gender and the original disease leading to HD. Radial BMD and oral calcitriol dose seemed to be important to predict the risk of hip fractures. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12169863     DOI: 10.1159/000065222

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  16 in total

Review 1.  The elderly patients on hemodialysis.

Authors:  S Anand; M Kurella Tamura; G M Chertow
Journal:  Minerva Urol Nefrol       Date:  2010-03       Impact factor: 3.720

Review 2.  Towards the revival of alkaline phosphatase for the management of bone disease, mortality and hip fractures.

Authors:  Wei Ling Lau; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2014-04-15       Impact factor: 5.992

3.  Bone fracture risk factors in prevalent hemodialysis patients.

Authors:  Patrícia João Matias; Ivo Laranjinha; Ana Azevedo; Ana Raimundo; David Navarro; Cristina Jorge; Inês Aires; Marco Mendes; Carina Ferreira; Tiago Amaral; Célia Gil; Aníbal Ferreira
Journal:  J Bone Miner Metab       Date:  2019-09-05       Impact factor: 2.626

4.  Bone mineral density by DXA and HR pQCT can discriminate fracture status in men and women with stages 3 to 5 chronic kidney disease.

Authors:  S A Jamal; A M Cheung; S L West; C E Lok
Journal:  Osteoporos Int       Date:  2012-12       Impact factor: 4.507

Review 5.  Fracture risk assessment in patients with chronic kidney disease.

Authors:  S A Jamal; S L West; P D Miller
Journal:  Osteoporos Int       Date:  2011-09-08       Impact factor: 4.507

Review 6.  Evaluation of fracture risk in chronic kidney disease.

Authors:  Pablo Antonio Ureña Torres; Martine Cohen-Solal
Journal:  J Nephrol       Date:  2017-04-06       Impact factor: 3.902

7.  Bone mineral density and fracture risk in older individuals with CKD.

Authors:  Robert H Yenchek; Joachim H Ix; Michael G Shlipak; Douglas C Bauer; Nahid J Rianon; Stephen B Kritchevsky; Tamara B Harris; Anne B Newman; Jane A Cauley; Linda F Fried
Journal:  Clin J Am Soc Nephrol       Date:  2012-04-19       Impact factor: 8.237

8.  Determinants of prevalent vertebral fractures and progressive bone loss in long-term hemodialysis patients.

Authors:  Jan Mares; Kristina Ohlidalova; Sylvie Opatrna; Jiri Ferda
Journal:  J Bone Miner Metab       Date:  2009-01-27       Impact factor: 2.626

9.  Associations between osteoprotegerin and femoral neck BMD in hemodialysis patients.

Authors:  Konstantinos K Doumouchtsis; Alkis I Kostakis; Stergios K Doumouchtsis; Marios P Tziamalis; Charalambos P Stathakis; Evanthia Diamanti-Kandarakis; Dimitrios Dimitroulis; Despoina N Perrea
Journal:  J Bone Miner Metab       Date:  2008-01-10       Impact factor: 2.626

10.  Geovariation in Fracture Risk among Patients Receiving Hemodialysis.

Authors:  James B Wetmore; Jiannong Liu; Heidi S Wirtz; David T Gilbertson; Kerry Cooper; Kimberly M Nieman; Allan J Collins; Brian D Bradbury
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-07       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.